Financhill
Sell
48

MNPR Quote, Financials, Valuation and Earnings

Last price:
$80.49
Seasonality move :
52.81%
Day range:
$79.50 - $85.01
52-week range:
$20.61 - $105.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.79x
Volume:
105.7K
Avg. volume:
159.4K
1-year change:
282.76%
Market cap:
$537.1M
Revenue:
--
EPS (TTM):
-$3.44

Earnings Data

Next earnings date for MNPR
Mar 24
2026
Most recent earnings per share
-$0.48
Missed by $0.08
(Nov 13/2025)
Consensus Estimate
-$0.40
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MNPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/24/2026 Q4 -- -- -- -$0.47 --
11/13/2025 Q3 -- -- -$0.48 -$0.40 -$0.08
08/12/2025 Q2 -- -- -$0.35 -$0.48 $0.13
05/13/2025 Q1 -- -- -$0.38 -$0.57 $0.19
03/31/2025 Q4 -- -- -$2.23 -$0.42 -$1.81
11/08/2024 Q3 -- -- -$0.37 -$1.17 $0.80
08/09/2024 Q2 -- -- -$0.49 -$0.47 -$0.02
05/09/2024 Q1 -- -- -$0.51 -$0.85 $0.34
03/28/2024 Q4 -- -- -$0.61 -$0.85 $0.24
11/09/2023 Q3 -- -- -$0.69 -$0.95 $0.26
08/11/2023 Q2 -- -- -$0.82 -- --
05/11/2023 Q1 -- -- -$0.93 -- --
03/23/2023 Q4 -- -- -$1.12 -- --
11/10/2022 Q3 -- -- -$0.94 -- --
08/11/2022 Q2 -- -- -$1.09 -- --
05/12/2022 Q1 -- -- -$0.97 -- --
03/24/2022 Q4 -- -- -$1.06 -- --
11/12/2021 Q3 -- -- -$0.98 -- --
08/12/2021 Q2 -- -- -$0.83 -- --
05/13/2021 Q1 -- -- -$0.78 -- --
03/25/2021 Q4 -- -- -$0.93 -- --
11/12/2020 Q3 -- -- -$0.74 -- --
08/06/2020 Q2 -- -- -$0.68 -- --
05/07/2020 Q1 -- -- -$0.51 -- --
03/27/2020 Q4 -- -- -$0.57 -- --
09/30/2019 Q3 -- -- -$0.35 -- --
06/30/2019 Q2 -- -- -$0.43 -- --
03/31/2019 Q1 -- -- -$0.65 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
09/30/2018 Q3 -- -- -$0.30 -- --
06/30/2018 Q2 -- -- -$0.39 -- --
03/31/2018 Q1 -- -- -$0.41 -- --
12/31/2017 Q4 -- -- -$0.34 -- --
09/30/2017 Q3 -- -- -$7.03 -- --
06/30/2017 Q2 -- -- -$0.28 -- --
03/31/2017 Q1 -- -- -$0.18 -- --
12/31/2016 Q4 -- -- -$0.15 -- --
09/30/2016 Q3 -- -- -$0.09 -- --

Monopar Therapeutics, Inc. Earnings Questions

  • How Much did Monopar Therapeutics, Inc. Generate in Revenue Last Quarter?

    Monopar Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Monopar Therapeutics, Inc. Beat Earnings Last Quarter?

    Monopar Therapeutics, Inc. announced earnings per share of -$0.48 which represents a miss of analyst forecast a -$0.40 per share.

  • Is Monopar Therapeutics, Inc. Profitable?

    Monopar Therapeutics, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Monopar Therapeutics, Inc. EPS Next Year?

    Monopar Therapeutics, Inc.'s earnings are forecast to decrease from -$4.11 per share to -$1.77 per share next year representing a decrease of -59.24%.

  • When is Monopar Therapeutics, Inc.'s Earnings Date?

    Monopar Therapeutics, Inc.'s next earnings date is March 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock